A Trial to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Liraglutide in Obese Children Aged 7 to 11 Years
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Novo Nordisk A/S
Related studies linked through entity extraction aliases.
A Trial Investigating the Cardiovascular Safety of Oral Semaglutide in Subjects With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec in Children and Adolescents With Type 1 Diabetes
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Safety and Effectiveness of NovoThirteen® (rFXIII) During Treatment of Congenital FXIII Deficiency in Japan
- Status
- COMPLETED
- Phase
- N/A
Investigating the Effectiveness of Tresiba® (Insulin Degludec) After Switching Basal Insulin in a Population With Type 1 or Type 2 Diabetes Mellitus
- Status
- COMPLETED
- Phase
- N/A
Effect of Liraglutide on Cardiovascular Endpoints in Diabetes Mellitus Type 2 Patients of South Asian Descent
- Status
- COMPLETED
- Phase
- PHASE4
Effect of Liraglutide on Diastolic Dysfunction on Cardiac MRI in Type 2 Diabetes Patients
- Status
- COMPLETED
- Phase
- PHASE4
Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart Twice Daily and Biphasic Insulin Aspart Twice Daily in Subjects With Type 2 Diabetes Mellitus Before, During and After Ramadan
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of Semaglutide Versus Dulaglutide as add-on to Metformin in Subjects With Type 2 Diabetes.
- Status
- COMPLETED
- Phase
- PHASE3
Pilot Study of the Effect of Liraglutide on Weight Loss and Gastric Functions in Obesity
- Status
- COMPLETED
- Phase
- PHASE2
A Comparative Trial Focusing on Injections With the Medical Device DV3316 Pen-injector Versus FlexPen®
- Status
- COMPLETED
- Phase
- PHASE1
Development of Pre-pregnancy Intervention to Reduce the Risk of Diabetes and Prediabetes
- Status
- COMPLETED
- Phase
- PHASE4
Evaluation of Automated Insulin Pump Settings Using the Advisor Pro (Previously Called) MD-Logic Pump Advisor-three Segments Study
- Status
- TERMINATED
- Phase
- NA
Investigating Efficacy and Safety of Once-weekly NNC0195-0092 Treatment Compared to Daily Growth Hormone Treatment (Norditropin® FlexPro®) in Growth Hormone Treatment naïve Pre-pubertal Children With Growth Hormone Deficiency
- Status
- COMPLETED
- Phase
- PHASE2
Molecular and Functional Neurobiology of Physical Exercise
- Status
- COMPLETED
- Phase
- NA
A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Subcutaneous NNC0143-0406 A 0.6 mmol/L in Subjects With Type 1 Diabetes
- Status
- COMPLETED
- Phase
- PHASE1
Estimation of Malignancy Rates Within Humedica Patient Populations Sampled to be Representative of Liraglutide Initiators and LEADER™ Trial Participants
- Status
- COMPLETED
- Phase
- N/A
Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE3
A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Japanese Subjects With Type 2 Diabetes Mellitus.
- Status
- COMPLETED
- Phase
- PHASE3
A Trial to Investigate Different Needle Features Assessed by Comparing Insulin Aspart Pharmacokinetic Profiles
- Status
- COMPLETED
- Phase
- PHASE1